Modulators of telomere disease

Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection

S Kammler, A Lopez, H Mueller, S Ottosen… - US Patent …, 2021 - Google Patents
2018-12-14 Assigned to F. HOFFMANN-LA ROCHE AG reassignment F. HOFFMANN-LA
ROCHE AG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS) …
被引用次数：7 相关文章 所有 4 个版本

PAPD5 and PAPD7 inhibitors for treating a hepatitis B infection

X Han, H Javanbakht, H Mueller, Y Wang… - US Patent …, 2021 - Google Patents
US11191775B2 - PAPD5 and PAPD7 inhibitors for treating a hepatitis B infection - Google
Patents US11191775B2 - PAPD5 and PAPD7 inhibitors for treating a hepatitis B infection …
被引用次数：6 相关文章 所有 4 个版本

Nucleic acid molecules for reduction of PAPD5 or PAPD7 mRNA for treating hepatitis B infection

H Javanbakht, S Ottosen, L Pedersen… - US Patent …, 2022 - Google Patents
2019-01-18 Assigned to F. HOFFMANN-LA ROCHE AG reassignment F. HOFFMANN-LA
ROCHE AG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS) …
被引用次数：5 相关文章 所有 4 个版本

Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection

S Kammler, A Lopez, H Mueller, S Ottosen… - US Patent …, 2022 - Google Patents
The present invention relates to nucleic acid molecules that are complementary to both PAP
associated domain containing 5 (PAPD5) and PAP associated domain containing 7 …
被引用次数：5 相关文章 所有 4 个版本

Oligonucleotides for modulating Tau expression

P Hagedorn, AM Høg, ML Jensen… - US Patent 11,279,929, 2022 - Google Patents
2019-07-17 Assigned to ROCHE INNOVATION CENTER COPENHAGEN A/S reassignment
ROCHE INNOVATION CENTER COPENHAGEN A/S ASSIGNMENT OF ASSIGNORS …
被引用次数：3 相关文章 所有 4 个版本

Oligonucleotides for modulating Tau expression

P Hagedorn, AM Høg, RE Olson… - US Patent 11,753,640, 2023 - Google Patents
The present invention relates to antisense oligonucleotides that are capable of modulating
expression of Tau in a target cell. The oligonucleotides hybridize to MAPT mRNA. The …
相关文章 所有 4 个版本